Renal Angiomyolipoma
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (1) | TSC1 oncogenic variants | Renal Angiomyolipoma | Everolimus | |
| FDA (1) | TSC2 oncogenic variants | Renal Angiomyolipoma | Everolimus |